Anthem Biosciences Limited — Shareholders meeting

Anthem Biosciences Limited has officially filed the voting results and the scrutinizers' report for its 20th Annual General Meeting (AGM) held on July 22, 2026, with the stock exchange. This regulatory filing confirms that the company has completed the formalities required to close the AGM proceedings. The submission of these documents is a standard procedural step that ensures transparency and compliance with market regulations.

For investors, this update signals that the AGM has concluded successfully and that the company is back to normal operations. While the specific agenda items and resolutions passed during the meeting are not detailed in this filing, the completion of the meeting is generally viewed positively as a sign of corporate governance and stability. Investors should monitor future announcements for any significant policy changes or strategic updates discussed during the AGM.